128 related articles for article (PubMed ID: 31053839)
1. Treatment of patients with HIV or hepatitis C by pharmacist clinicians in a patient-centered medical home.
Ryan KL; Jakeman B; Conklin J; Pineda LJ; Deming P; Mercier RC
Am J Health Syst Pharm; 2019 May; 76(11):821-828. PubMed ID: 31053839
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution.
Gauthier TP; Moreira E; Chan C; Cabrera A; Toro M; Carrasquillo MZ; Corentin M; Sherman EM
J Am Pharm Assoc (2003); 2016; 56(6):670-676. PubMed ID: 27667501
[TBL] [Abstract][Full Text] [Related]
3. Integration of pharmacists into a patient-centered medical home.
Scott MA; Hitch B; Ray L; Colvin G
J Am Pharm Assoc (2003); 2011; 51(2):161-6. PubMed ID: 21382805
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Economic Effects of a Pharmacist-Administered Antiretroviral Therapy Adherence Clinic for Patients Living with HIV.
Dilworth TJ; Klein PW; Mercier RC; Borrego ME; Jakeman B; Pinkerton SD
J Manag Care Spec Pharm; 2018 Feb; 24(2):165-172. PubMed ID: 29384024
[TBL] [Abstract][Full Text] [Related]
5. Incorporating a pharmacist into an interprofessional team providing transgender care under a medical home model.
Newsome C; Colip L; Sharon N; Conklin J
Am J Health Syst Pharm; 2017 Feb; 74(3):135-139. PubMed ID: 28122755
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of pharmacist care delivery models for hepatitis C clinics.
Naidjate SS; Zullo AR; Dapaah-Afriyie R; Hersey ML; Marshall BDL; Winkler RM; Berard-Collins C
Am J Health Syst Pharm; 2019 May; 76(10):646-653. PubMed ID: 30873537
[TBL] [Abstract][Full Text] [Related]
7. Pharmacist-provided services and community pharmacist integration into a patient-centered medical home: A qualitative study of primary care clinic staff perceptions.
Bates KA; Stafford RA; Teeter BS; Diemer T; Thomas JL; Curran GM
J Am Pharm Assoc (2003); 2019; 59(4S):S6-S11.e1. PubMed ID: 31101441
[TBL] [Abstract][Full Text] [Related]
8. A sustainable business model for comprehensive medication management in a patient-centered medical home.
Fabel PH; Wagner T; Ziegler B; Fleming PA; Davis RE
J Am Pharm Assoc (2003); 2019; 59(2):285-290. PubMed ID: 30611660
[TBL] [Abstract][Full Text] [Related]
9. Academic pharmacy and patient-centered health care: a model to prepare the next generation of pharmacists.
Haines SL; DeHart RM; Flynn AA; Hess KM; Marciniak MW; Mount J; Phillips BB; Saseen JJ; Zatzkin SW
J Am Pharm Assoc (2003); 2011; 51(2):194-202. PubMed ID: 21382810
[TBL] [Abstract][Full Text] [Related]
10. Different models of pharmaceutical services and care in primary healthcare clinics in the Eastern Cape, South Africa: Challenges and opportunities for pharmacy practice.
Bobbins AC; Burton S; Fogarty TL
Afr J Prim Health Care Fam Med; 2020 Jul; 12(1):e1-e11. PubMed ID: 32787403
[TBL] [Abstract][Full Text] [Related]
11. Pharmacist-driven multidisciplinary pretreatment workup process for hepatitis C care: A novel model for same-day pretreatment workup.
Houck KK; Ifeachor AP; Fleming BS; Andres AM; O'Donovan KN; Johnson AJ; Liangpunsakul S
J Am Pharm Assoc (2003); 2019; 59(5):710-716. PubMed ID: 31227418
[TBL] [Abstract][Full Text] [Related]
12. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
13. Integration of collaborative medication therapy management in a safety net patient-centered medical home.
Moczygemba LR; Goode JV; Gatewood SB; Osborn RD; Alexander AJ; Kennedy AK; Stevens LP; Matzke GR
J Am Pharm Assoc (2003); 2011; 51(2):167-72. PubMed ID: 21382806
[TBL] [Abstract][Full Text] [Related]
14. Opportunities and considerations for pharmacist intervention in the management of the chronic hepatitis C patient.
Walters-Smith N; Marshall SM
J Manag Care Pharm; 2009 Jun; 15(5):417-9. PubMed ID: 19496639
[No Abstract] [Full Text] [Related]
15. The critical need for pharmacist involvement in the management of patients with hepatitis C.
Spooner LM
J Manag Care Pharm; 2009 Mar; 15(2):151-3. PubMed ID: 19236129
[No Abstract] [Full Text] [Related]
16. Outcome of challenging HIV case consultations provided via teleconference by the Clinician Consultation Center to the Federal Bureau of Prisons.
Dong BJ; Williams MR; Bingham JT; Tokumoto J; Allen JD
J Am Pharm Assoc (2003); 2017; 57(4):516-519. PubMed ID: 28610939
[TBL] [Abstract][Full Text] [Related]
17. Retention in HIV Care Among Participants in the Patient-Centered HIV Care Model: A Collaboration Between Community-Based Pharmacists and Primary Medical Providers.
Byrd KK; Hardnett F; Clay PG; Delpino A; Hazen R; Shankle MD; Camp NM; Suzuki S; Weidle PJ;
AIDS Patient Care STDS; 2019 Feb; 33(2):58-66. PubMed ID: 30648888
[TBL] [Abstract][Full Text] [Related]
18. A patient-centered pharmacy services model of HIV patient care in community pharmacy settings: a theoretical and empirical framework.
Kibicho J; Owczarzak J
AIDS Patient Care STDS; 2012 Jan; 26(1):20-8. PubMed ID: 22149903
[TBL] [Abstract][Full Text] [Related]
19. Interdisciplinary Care Team with Pharmacist in a Community-based HIV Clinic.
Samuel O; Unonu JM; Dotson K; Park S; Parker R; Wutoh AK; Lee E
J Natl Med Assoc; 2018 Aug; 110(4):378-383. PubMed ID: 30126564
[TBL] [Abstract][Full Text] [Related]
20. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
Kieran J; Dillon A; Farrell G; Jackson A; Norris S; Mulcahy F; Bergin C
Int J STD AIDS; 2011 Oct; 22(10):571-6. PubMed ID: 21998177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
